Q&A with Hardman & Co: Real Estate Credit Investments (LON:RECI)
16 September 2019
Scholar Rock Holding Corporation (NASDAQ: SRRK), a budding entity in the biotechnology landscape, commands attention with its promising pipeline and a robust market cap of $4.44 billion. Headquartered in Cambridge,..
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is capturing investor attention with its ambitious pipeline and potential for significant upside. As a biotechnology company focused on rare and ultra-rare genetic diseases, Ultragenyx..
Beam Therapeutics Inc. (NASDAQ: BEAM) is making waves in the biotechnology sector with its precision genetic medicines, targeting serious diseases through innovative therapies. With a market capitalization of $2.91 billion,..
Investors interested in the healthcare sector, particularly the niche market of behavioral healthcare services, may find Acadia Healthcare Company, Inc. (NASDAQ: ACHC) a noteworthy candidate. With a market capitalization of..
Brookdale Senior Living Inc. (BKD) is a pivotal player in the healthcare sector, specifically within the medical care facilities industry in the United States. With a market capitalization of $3.6..
Viking Therapeutics, Inc. (NASDAQ: VKTX) has emerged as a compelling player in the biotechnology sector, capturing the attention of investors with its innovative pipeline and substantial upside potential. With a..
PACS Group, Inc. (PACS), a prominent player in the healthcare sector, is capturing investor attention with its impressive potential upside of 20.63%. Specializing in the operation of skilled nursing and..
Alvotech (NASDAQ: ALVO), a Luxembourg-based company specializing in the development and manufacture of biosimilar medicines, has caught the attention of investors with its promising growth potential. Despite a current price..
Investors with an eye on the biotechnology sector might find Galapagos NV (NASDAQ: GLPG) a compelling company to consider, especially given its striking revenue growth of 1,093.20%. Based in Mechelen,..
Edgewise Therapeutics, Inc. (EWTX), a burgeoning name in the biotechnology sector, is capturing the attention of investors with its promising 35.24% potential upside. The company’s focus on developing groundbreaking therapies..
Investors eyeing opportunities in the healthcare sector may want to take a closer look at Kiniksa Pharmaceuticals International (NASDAQ: KNSA). With a market capitalization of $3.49 billion and a unique..
Ardent Health, Inc. (NYSE: ARDT) stands out in the healthcare sector as a robust player in the medical care facilities industry. With a market capitalization of $1.36 billion, this Brentwood,..
For investors with a keen interest in the healthcare sector, Organon & Co. (NYSE: OGN) offers a compelling case study. With a market capitalization of $1.87 billion, this U.S.-based company..
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is capturing the attention of growth-oriented investors with its compelling development pipeline and an eye-catching potential upside of 105.26%. The company, headquartered in San Diego,..
ICU Medical, Inc. (NASDAQ: ICUI) presents a compelling opportunity for investors seeking exposure in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of..
ImmunityBio, Inc. (NASDAQ: IBRX) stands as a formidable player in the biotechnology sector, capturing investor interest with its innovative approach to immunotherapy. With a market cap of $10.73 billion, this..
Select Medical Holdings Corporation (NYSE: SEM) stands as a formidable entity within the healthcare sector, particularly in the medical care facilities industry. With a market capitalization of $1.86 billion, this..
Addus HomeCare Corporation (NASDAQ: ADUS) stands as a notable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.95 billion, Addus is..
Investors seeking opportunities in the healthcare sector may find Enovis Corporation (ENOV) an intriguing choice, especially with a potential upside of 75.8% as indicated by the average target price set..
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a biopharmaceutical leader in rare and orphan diseases, is making waves in the biotechnology sector with its innovative therapies and robust growth prospects. With a..
